We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
-3.87%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$103M
AUM Growth
-$4.33M
(-4.1%)
Cap. Flow
+$2.78M
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
35.3%
Holding
106
New
24
Increased
11
Reduced
49
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$4.44M |
| 2 |
Granite Construction
GVA
|
+$1.62M |
| 3 |
Designer Brands
DBI
|
+$1.4M |
| 4 |
Nu Skin
NUS
|
+$1.35M |
| 5 |
SCPL
SciPlay Corporation Class A Common Stock
SCPL
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RingCentral
RNG
|
+$2.9M |
| 2 |
QADA
QAD Inc.
QADA
|
+$2.13M |
| 3 |
Collegium Pharmaceutical
COLL
|
+$1.71M |
| 4 |
PBF Energy
PBF
|
+$1.2M |
| 5 |
POLY
Plantronics, Inc.
POLY
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.22% |
| 2 | Healthcare | 22.49% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Communication Services | 9.28% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Wintrust Financial
WTFC
$11B
| – | – |
-2,816
| Closed | -$206K |
|
|
ICPT
102
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-7,733
| Closed | -$615K |
|
|
POLY
103
DELISTED
Plantronics, Inc.
POLY
| – | – |
-29,253
| Closed | -$1.08M |
|
|
TSG
104
DELISTED
The Stars Group Inc.
TSG
| – | – |
-40,916
| Closed | -$698K |
|
|
CBLK
105
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| – | – |
-40,197
| Closed | -$672K |
|
|
QADA
106
DELISTED
QAD Inc.
QADA
| – | – |
-52,862
| Closed | -$2.13M |
|
Similar funds
KA
DEA
EAN
PIP
SC
L
LB
ACM
1492 Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, 1492 Capital Management held 106 positions worth $103M, down 4.1% from $107M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
1492 Capital Management's Q3 2019 filing shows 24 new, 11 increased, 49 reduced and 16 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 171,621 shares worth $4.67M. The largest sale was RingCentral, an estimated $2.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 1492 Capital Management's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 171,621 shares worth $4.67M.
- 1492 Capital Management added most to Kratos Defense & Security Solutions in Q3 2019, an estimated $531K increase.
- 1492 Capital Management's biggest Q3 2019 reduction was RingCentral, cutting an estimated $2.9M.
- 1492 Capital Management fully exited QAD Inc. in Q3 2019, selling an estimated $2.13M.
- 1492 Capital Management's ten largest holdings make up 35% of its $103M portfolio in Q3 2019.
- 1492 Capital Management opened 24 new positions and closed 16 in Q3 2019.
- 1492 Capital Management's portfolio value fell 4.1% quarter-over-quarter to $103M.
Based on 1492 Capital Management's 13F filing for Q3 2019, filed 5 Nov 2019.